Effects of cerebral ischemia on regional dopamine release and D1 and D2 receptors

C J Chang1, H Ishii, H Yamamoto

  • 1Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.

Insights

Ischemia significantly increases dopamine release in the striatum and cortex of gerbils. This ischemic event alters dopamine receptor binding, affecting neurotransmission.

Area of Science:

  • Neuroscience
  • Cerebrovascular Research
  • Neurochemistry

Background:

  • Regional cerebral vulnerability to ischemia is not fully understood.
  • Dopamine (DA) neurotransmission plays a role in brain function and may be affected by ischemic events.

Purpose of the Study:

  • To investigate the release of dopamine and the characteristics of dopaminergic receptors in response to ischemia.
  • To explore regional differences in cerebral vulnerability to ischemia.

Main Methods:

  • Mongolian gerbils underwent transient bilateral carotid artery occlusion.
  • Extracellular dopamine and metabolite levels were measured using microdialysis and HPLC.
  • Dopamine D1 and D2 receptor binding kinetics were assessed using radiolabeled ligands.

Main Results:

  • Striatal dopamine release was significantly higher (400-fold) than cortical release (12-fold) during ischemia.
  • Ischemia decreased D1 receptor affinity in the cortex and reduced D2 receptor binding sites in the striatum.
  • No significant changes in D1 or D2 receptor binding were observed in the ischemic cortex or post-ischemic striatum/cortex.

Conclusions:

  • Striatal dopamine release is markedly elevated during ischemia.
  • Early, transient alterations in D1 and D2 receptor-mediated dopamine neurotransmission occur in the striatum following ischemia.
  • These findings suggest a role for dopamine system changes in regional cerebral vulnerability to ischemic injury.

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...